Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in behaviour therapy for obsessive-compulsive disorder

J H Greist1

  • 1Dean Foundation for Health, Research and Education, Madison, WI 53717-1914, USA.

International Clinical Psychopharmacology
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Running Out of Depression.

The Physician and sportsmedicine·2016
Same author

Do subtle neurological impairments predict treatment resistance to clomipramine in children and adolescents with obsessive-compulsive disorder?

Journal of child and adolescent psychopharmacology·2009
Same author

Lay person-based screening for early detection of Alzheimer's disease: development and validation of an instrument.

The journals of gerontology. Series B, Psychological sciences and social sciences·2002
Same author

Comparison of interactive voice response and written self-administered patient surveys for clinical research.

Orthopedics·2002
Same author

Computer-automated dementia screening using a touch-tone telephone.

Archives of internal medicine·2001
Same author

Impact of generalized social anxiety disorder in managed care.

The American journal of psychiatry·2001
Same journal

Critical reassessment of manic and psychotic episodes related to levetiracetam: a systematic review of published case reports.

International clinical psychopharmacology·2026
Same journal

Expanding the horizon of brexpiprazole augmentation in treatment-resistant disorders: from obsessive-compulsive disorder to adolescent bipolar disorder.

International clinical psychopharmacology·2026
Same journal

Acceptability-adjusted speed in psychotic agitation: interpreting pro re nata antipsychotic data in real-world care (commentary on Hatta et al.).

International clinical psychopharmacology·2026
Same journal

Antipsychotics in clinical practice: agitation, polypharmacy, and treatment resistance.

International clinical psychopharmacology·2026
Same journal

Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.

International clinical psychopharmacology·2026
Same journal

Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).

International clinical psychopharmacology·2026
See all related articles

Exposure and response prevention (ERP) is an effective behavior therapy for obsessive-compulsive disorder (OCD). While challenging to implement, ERP shows significant short- and long-term effectiveness, comparable to serotonin reuptake inhibitors.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Behavioral Science

Background:

  • Obsessive-compulsive disorder (OCD) is a debilitating mental health condition.
  • Exposure and response prevention (ERP) is a primary behavioral intervention for OCD, based on habituation principles.
  • While conceptually simple, ERP can be difficult to implement and sustain.

Purpose of the Study:

  • To review the effectiveness and acceptability of behavior therapy techniques for OCD.
  • To discuss challenges hindering the wider dissemination of behavior therapy for OCD.
  • To present preliminary findings on a computer-administered ERP program, BT STEPS.

Main Methods:

  • Review of controlled trials and meta-analyses on behavior therapy for OCD.
  • Examination of studies supporting the efficacy and patient acceptance of ERP.

Related Experiment Videos

  • Presentation of initial results from the BT STEPS computer-administered program.

    • Main Results:

    • Behavior therapy, particularly ERP, is proven effective in short- and long-term treatment of OCD.
    • Meta-analyses indicate behavior therapy is as effective as serotonin reuptake inhibitors (SRIs).
    • Preliminary data on the computer-administered BT STEPS program are presented.

    Conclusions:

    • Behavior therapy, especially ERP, is a highly effective treatment for OCD.
    • Combined behavioral and pharmacological approaches may offer optimal OCD treatment.
    • Addressing implementation challenges is crucial for broader access to effective OCD therapies.